28th - 29th November 2023
Hybrid Event | Berlin | Germany
Today’s bioprocessing is the base of different emerging industries and technologies, including the production of therapeutic stem cells, gene therapy vectors, and new vaccines. Advances in bioprocessing is a special interest to the industry as it highly shortens the development timeline, improves the final product and increases the productivity of Bio-manufacturing facilities.
In this conference, leaders in biopharmaceutical production investigate the latest technologies and manufacturing strategies for next generation biologics and advanced therapies. It will mainly focus on main challenges within the field, assessing innovative solutions such as continuous bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high quality standards.
This topic is very interesting and the need for bioprocessing and biologics is growing fast worldwide. This international forum will have an emphasis on change, developments, improvements, new directions, and management of biologics and bio-processing with focus on technical rather than commercial achievements.